Evidence map›Paper›PMID 35628765›Full record

ArticleJournal of fungi (Basel, Switzerland)2022

Gram-Level Production of Balanol through Regulatory Pathway and Medium Optimization in Herb Fungus

Rui-Qi Li, Xiang Liu, Min Zhang, Wei-Qun Xu, Yong-Quan Li, Xin-Ai Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rui-Qi LiSchool of Medicine and the Children's Hospital, Zhejiang University, Hangzhou 310058, China.
Xiang LiuSchool of Medicine and the Children's Hospital, Zhejiang University, Hangzhou 310058, China.
Min ZhangSchool of Medicine and the Children's Hospital, Zhejiang University, Hangzhou 310058, China.
Wei-Qun XuSchool of Medicine and the Children's Hospital, Zhejiang University, Hangzhou 310058, China.
Yong-Quan LiInstitute of Pharmaceutical Biotechnology, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0001-6013-4068
Xin-Ai ChenSchool of Medicine and the Children's Hospital, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-4478-771X
Children's Hospital of Zhejiang University · CNZhejiang University · CN

Funding

the National Key R&D Program of China "2018YFA0903200" and "2021YFC2100600"
6 · The paper itself

Abstract

As a potential protein kinase C inhibitor, the fungus metabolite balanol has become more attractive in recent decades. In our previous work, we revealed its biosynthetic pathway through overexpression of the cluster-situated regulator gene

Indexed as

balanol biosynthesisfermentationmedium optimizationprotein kinase C inhibitorregulator BlnRTolypocladium ophioglossoidesZn2Cys6

Identifiers

PMID35628765
PMCPMC9143294
OpenAlexW4280632384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.